Literature DB >> 2843795

Hypomanic reactions to ACTH and prednisone treatment for multiple sclerosis.

S L Minden1, J Orav, J J Schildkraut.   

Abstract

Nine of 50 MS patients became hypomanic or manic during treatment with ACTH or prednisone. Symptoms did not occur with every drug exposure and were more common with ACTH. Patients at risk were identified by episodes of major depression before and after the onset of MS and by family histories of depression or alcoholism.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2843795     DOI: 10.1212/wnl.38.10.1631

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  15 in total

1.  Multiple sclerosis and the mind.

Authors:  M A Ron; A Feinstein
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-01       Impact factor: 10.154

Review 2.  Adverse neurologic effects of glucocorticosteroids.

Authors:  D Lacomis; M A Samuels
Journal:  J Gen Intern Med       Date:  1991 Jul-Aug       Impact factor: 5.128

Review 3.  White matter hyperintensities: from medical comorbidities to bipolar disorders and back.

Authors:  Eva Gunde; Ryan Blagdon; Tomas Hajek
Journal:  Ann Med       Date:  2011-07-13       Impact factor: 4.709

Review 4.  Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management.

Authors:  S B Patten; C I Neutel
Journal:  Drug Saf       Date:  2000-02       Impact factor: 5.606

Review 5.  Prevention and treatment of systemic glucocorticoid side effects.

Authors:  Siamak Moghadam-Kia; Victoria P Werth
Journal:  Int J Dermatol       Date:  2010-03       Impact factor: 2.736

Review 6.  The neurobiology of the switch process in bipolar disorder: a review.

Authors:  Giacomo Salvadore; Jorge A Quiroz; Rodrigo Machado-Vieira; Ioline D Henter; Husseini K Manji; Carlos A Zarate
Journal:  J Clin Psychiatry       Date:  2010-05-04       Impact factor: 4.384

Review 7.  Corticosteroid-induced neuropsychiatric disorders: review and contrast with neuropsychiatric lupus.

Authors:  Samir D Bhangle; Neil Kramer; Elliot D Rosenstein
Journal:  Rheumatol Int       Date:  2013-04-16       Impact factor: 2.631

Review 8.  Drug-induced mania.

Authors:  M Peet; S Peters
Journal:  Drug Saf       Date:  1995-02       Impact factor: 5.606

Review 9.  Neuropsychological aspects of multiple sclerosis.

Authors:  J C Brassington; N V Marsh
Journal:  Neuropsychol Rev       Date:  1998-06       Impact factor: 7.444

Review 10.  Psychiatric issues in multiple sclerosis.

Authors:  Lydia A Chwastiak; Dawn M Ehde
Journal:  Psychiatr Clin North Am       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.